New injection could smooth away neck bands

NCT ID NCT07210463

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This phase 3 trial tests whether NT 201 (a botulinum toxin injection) can safely reduce the appearance of moderate to severe neck bands (platysma prominence) in adults. About 300 participants in Europe will receive either NT 201 or a placebo injection. The study measures improvement using a doctor's and participant's rating scale at two weeks after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NT 201 (incobotulinumtoxinA, a botulinum toxin type A injection)
What this could lead to
If it works, this could provide a safe and effective cosmetic treatment to reduce the appearance of prominent neck bands.
What could go wrong
This is a cosmetic trial, so the main risk is that the treatment may not improve neck band appearance more than placebo. Side effects like injection site reactions or muscle weakness are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACETYLCHOLINE RELEASE INHIBITORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Merz Investigative Site

    Lyon, 69006, France

  • Merz Investigative Site

    Munich, Bavaria, 80539, Germany

  • Merz Investigative Site

    Blankenfelde-Mahlow, Brandenburg, 15831, Germany

  • Merz Investigative Site

    Potsdam, Brandenburg, 14467, Germany

  • Merz Investigative Site

    Friedrichsdorf, Hesse, 61381, Germany

  • Merz Investigative Site

    Kassel, Hesse, 34117, Germany

  • Merz Investigative Site

    Bochum, North Rhine-Westphalia, 44793, Germany

  • Merz Investigative Site

    Düsseldorf, North Rhine-Westphalia, 40212, Germany

  • Merz Investigative Site

    Drensteinfurt, 48317, Germany

  • Merz Investigative Site

    Hamburg, 20146, Germany

  • Merz Investigative Site

    Hamburg, 29354, Germany

  • Merz Investigative Site

    Wuppertal, 42287, Germany

  • Merz Investigative Site

    Krakow, Lesser Poland Voivodeship, 30-002, Poland

  • Merz Investigative Site

    Oświęcim, Lesser Poland Voivodeship, 32-600, Poland

  • Merz Investigative Site

    Lublin, Lublin Voivodeship, 20-607, Poland

  • Merz Investigative Site

    Warsaw, Masovian Voivodeship, 00-716, Poland

  • Merz Investigative Site

    Warsaw, Masovian Voivodeship, 01-142, Poland

  • Merz Investigative Site

    Warsaw, Masovian Voivodeship, 02-482, Poland

  • Merz Investigative Site

    Warsaw, Masovian Voivodeship, 02-953, Poland

  • Merz Investigative Site

    Bialystok, Podlaskie Voivodeship, 15-453, Poland

  • Merz Investigative Site

    Gdynia, Pomeranian Voivodeship, 81-537, Poland

  • Merz Investigative Site

    Warsaw, 02-962, Poland

  • Merz Investigative Site

    Lodz, Łódź Voivodeship, 90-436, Poland

  • Merz Investigative Site

    Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship, 27-400, Poland

  • Merz Investigative Site

    Pamplona, Navarre, 31008, Spain

  • Merz Investigative Site

    Valencia, 46010, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.